New GLP-1 Oral Medication Shows Promise for Cardiovascular Safety
02/10/2026
Introducción The recent ACHIEVE-4 trial evaluated orforglipron (Foundayo), an oral GLP-1 receptor agonist, demonstrating cardiovascular safety though its heart benefits
La actriz ganadora de un Emmy, Christina Applegate, reveló recientemente que su diagnóstico de esclerosis múltiple (EM), que anunció por…
Read more →
Introducción The recent ACHIEVE-4 trial evaluated orforglipron (Foundayo), an oral GLP-1 receptor agonist, demonstrating cardiovascular safety though its heart benefits
In a recent commentary, Michael Silverstein, MD, MPH, a former chair of the U.S. Preventive Services Task Force (USPSTF), revealed
Should Medicare’s annual wellness visit (AWV) rely more on artificial intelligence (AI) than on traditional physician-led processes? This question has
Introducción “Entonces, Dr. Pelzman, ¿qué debo hacer con todos estos resultados de pruebas?” Esta pregunta parece ser un mensaje frecuente
Context of Bulimia Actor Sylvester Stallone, 80, has shared his experience with bulimia, revealing that his determination to maintain a